FGF1 and myocardial infarction: In an MI rat model, the administration of microparticles loaded with Fibroblast growth factor 1 (FGF1) and Nrg1 after MI leads to cardiac function improvement, smaller infarct size, reduction of fibrosis and induction of tissue revascularization [139].